{
  "id": 1,
  "text": "=== Page 59 ===\nIBA Annual Report 2023 \n56. IBA \ntransactions, with reporting to the Audit \nCommittee of the Group four times a year. The Group has certain investments In foreign \noperations, whose net assets are exposed to \nforeign currency translation risk. As appropriate, currency exposure arising from the net assets of \nthe Groups foreign operations may be managed \nthrough borrowings denominated in the relevant \ncurrencies. Proton Therapy segment is impacted by the \nfluctuation of the USD exchange rate against \nEUR.",
  "similarity_score": 0.4014435260925653
}